Lastly, our Uba6/Ub-AMP structures, and in particular, differences with the human Uba1 active site, will provide a framework for drug discovery efforts targeting specifically this enzyme for therapeutic intervention in cancer and other diseases. This evidence concerns the gene UBA1 and cancer.